Molecular Pathology Insights into Non-Malignant Hematological Disorders

1

Molecular pathology has significantly advanced the diagnosis and management of hematological disorders, particularly hemoglobinopathies.
2

Hemoglobinopathies, including sickle cell disease and thalassemia, are the most prevalent non-malignant hematological disorders globally.
3

The Global Burden of Disease study reported over 104,600 deaths due to hemoglobinopathies and hemolytic anemias in 2017.
4

G6PD deficiency and other hematological diseases also contribute to global morbidity, with significant years lived with disability.
5

Advancements in molecular genetics have clarified the genetic basis of hemoglobinopathies, aiding in targeted therapeutic options.

1